| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ead6158fa635796a5fa4d48ffc357a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2523-125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1473362090d28b3b231f7b2bbfbb3aee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70bf0de9e61f8d34ae2a52a3fbfb3882 |
| publicationDate |
2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1702989-A1 |
| titleOfInvention |
Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment |
| abstract |
The present invention relates to a method for classifying non-small-cell lung cancer (NSCLC) patients, for selecting an effective chemotherapy and for predicting survival of those NSCLC patients, based on the determination of the trnetlxylation level of the 14-3-3 sigma gene. The methylation status of the 34-3-3 sigma gene can be easily determined in a serum sample. |
| priorityDate |
2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |